Abstract��OBJECTIVE To explore the antitumor effect and immunity change of Periplaneta americana C��3 and related synthetic peptide HFDT1 in mice and to provide a base for clinical application of the materials. METHODS Sixty BALB/c mouse tumor model with leukemia L1210 were established and divided into five groups. The mice were treated with Periplaneta americana C��3 high dose, low dose, HFDT1, CTX and normal saline for 10 d, respectively. Twelve mice were as normal control group. The tumor inhibition rates and weight of body were observed in different groups. Then the results were observed including thymus and spleen index, the numbers of immune cells in peripheral blood, the ratio of splenic total lymphocytes, splenic B cell(CD45R+)and T cell(CD3+), T cell subset(CD3+CD4+ and CD3+CD8+ T cell), and the levels of IgG, IgA and IgM in serum through weight, auto-analysis of blood cell, flow cytometry, sandwich-antibody ELISA from thymus, spleen, peripheral blood in the mice. RESULTS The results showed that C��3 and HFDT1 inhibited the growth of mouse L1210 tumor and maintained the mouse weights. They increased the mouse thymus indexes and spleen indexes effectively and the numbers of peripheral blood immune cells. They maintained the spleen lymphocyte and regulated the ratio of T and B lymphocytes, CD3+CD4+ T cell and CD3+CD8+T cell. They increased the levels of serum IgG, IgA and IgM. CONCLUSIONPeriplaneta americana extract C��3 and related synthetic peptide HFDT1 have a strong inhibition effect to tumor. The antitumor effect of C��3 and HFDT1 may be achieved through to improve immune function. They are hoped to become efficient and low toxicity antitumor drugs. Especially HFDT1, it has an extensive application because it can be synthesized by artificial methods.
LI J T,ZHANG J L,HE H,et al. Apoptosis in human hepatoma HepG2 cells induced by corn peptides and its anti-tumor efficacy in H22 tumor bearing mice[J].Food Chem Toxicol,2013,51(34):297-305.
[2]
CHERNYSH S,KIM S I,BEKKER G,et al.Antiviral and antitumor peptides from insects[J].Proc Natl Acad Sci USA,2002,99(20):12628-12632.
[3]
DU Q S,XIE N Z,HUANG R B. Recent development of peptide drugs and advance on theory and methodology of peptide inhibitor design[J]. Med Chem,2015,11(3):235-247.
[4]
ZHAO W,BAI L. Research advance in peptide drugs and anti- tumor[J]. Basic Clin Med(����ҽѧ���ٴ�),2014,34(7):999-1001.
[5]
KO J K,AUYEUNG K K. Identification of functional peptides from natural and synthetic products on their anticancer activities by tumor targeting[J]. Curr Med Chem,2014,21(21):2346-2356.
[6]
RADULESCU R T. The practical utility of synthetic tumor suppressor peptides:a personal retrospective on 25 years[J]. Rom J Morphol Embryol,2014,55(1):217-220.
[7]
HE Z C,PENG F,SONG L Y,et al. Review on investigations related to chemical constituents and biological activities of Periplaneta americana[J]. China J Chin Mater Med(�й���ҩ��־),2007,32(21):2326-2331.
[8]
YU S S,ZHANG H,ZHANG T T,et al. Research advances in pharmacological action and clinical application of Periplaneta americana[J]. J Liaoning Univ Tradit Chin Med(������ҽҩ��ѧѧ��),2016,18(4):228-231.
[9]
ZHAO W. The function of Periplaneta americana extract in anti-tumor immune regulation [D]. Dali: Dali Universtiy,2015.
[10]
Dali Universtiy. Periplaneta americana one kind of immunomodulatory peptides and their preparation and pharmaceutical use:China,2017100567877 [P]. 2017-01-26.
[11]
JIANG Y X,WANG X C,JING C G,et al. The inhibitory effect of Periplaneta americana extract on lewis lung cancer in mice[J]. J Kunming Med Coll(����ҽѧԺѧ��), 2007,28(5):13-16.
[12]
JIANG Y X,WANG X C,JING C G,et al. Inhibitory effect of Periplaneta americana extract on 3LL lung cancer in mice[J]. Clin J Lung Cancer(�й��ΰ���־),2006,9(6):488-491.
[13]
WANG X Y,HE Z C,SONG L Y,et al. Chemotherapeutic effects of bioassay-guided extracts of the American cockroach,Periplaneta americana[J]. Integr Cancer Ther,2011,10(3):12-23.
[14]
LIU Z W,ZHANG S,LI Z F. Spleen and tumor[J]. Mod Oncol(�ִ�����ҽѧ),2009,17(S1):90-92.
WANG L,SHEN Y. Imbalance of circulating T-lymphocyte subpopulation in gastric cancer patients correlated with performance status[J]. Clin Lab,2013,59(3):429-433.
[17]
LI L,ZHANG P,KANG H Z,et al. Risk factors for nosocomial infections during myelosuppression period of tumour chemotherapy[J]. Chin J Nosocomiol(�л�ҽԺ��Ⱦѧ��־),2013,23(18):4394-4398.
2018, Vol. 53 
